These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 6229812)

  • 1. Progress in the measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinogen derivatives in plasma.
    Lane DA
    Br J Haematol; 1981 Mar; 47(3):329-35. PubMed ID: 6161635
    [No Abstract]   [Full Text] [Related]  

  • 3. Disseminated intravascular coagulation: the application and utility of diagnostic tests.
    Ockelford PA; Carter CJ
    Semin Thromb Hemost; 1982 Jul; 8(3):198-216. PubMed ID: 6215711
    [No Abstract]   [Full Text] [Related]  

  • 4. Radioimmunoassays of human fibrinopeptides A and B.
    Budzyński AZ; Marder VJ
    Pol Arch Med Wewn; 1978 Jan; 59(1):43-8. PubMed ID: 349523
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinogen proteolysis by thrombin, plasmin and platelet release in relation to disseminated intravascular coagulation.
    Nossel HL
    Bibl Haematol; 1983; (49):151-62. PubMed ID: 6230075
    [No Abstract]   [Full Text] [Related]  

  • 6. Markers of fibrinogen derivatives used in clinical investigation.
    Soria J; Soria C; Mirshahi M; Samama MM
    Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular basis for measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Hemost Thromb; 1978; 4():211-48. PubMed ID: 152445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical significance of fibrinogen degradation products.
    Bick RL
    Semin Thromb Hemost; 1982 Oct; 8(4):302-30. PubMed ID: 6758120
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of fibrinogen/fibrin degradation products (F/F DP)].
    Alakhverdian R
    Vutr Boles; 1979; 18(3):160-7. PubMed ID: 89851
    [No Abstract]   [Full Text] [Related]  

  • 11. [Molecular markers of hemostatic mechanisms--fibrinopeptide B beta 1-42].
    Kuroso K
    Rinsho Byori; 1989 Mar; 37(3):234-9. PubMed ID: 2664279
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural considerations of plasmic degradation of fibrinogen.
    Marder VJ; Budzynski AZ
    Pathol Biol (Paris); 1974 Nov; 22 suppl():43-6. PubMed ID: 4283397
    [No Abstract]   [Full Text] [Related]  

  • 13. [Approach of hematology. Abnormal findings of coagulation and fibrinolytic factors in DIC].
    Ikematsu S; Kato M; Kuroso K
    Rinsho Byori; 1984 Aug; 32(8):862-8. PubMed ID: 6502985
    [No Abstract]   [Full Text] [Related]  

  • 14. [An analysis of disseminated intravascular coagulation by fibrinopeptides].
    Gando S; Tedo I
    Rinsho Ketsueki; 1988 Dec; 29(12):2250-5. PubMed ID: 3150013
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinogen and its derivatives in intravascular coagulation. A review.
    Gerrits WB
    Neth J Med; 1975; 18(1):31-44. PubMed ID: 124019
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
    Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrinopeptide A (FPA), fibrinopeptide B (FPB) and fibrinopeptide Bbeta(15-42) (FPBbeta15-42)].
    Uchiba M; Okajima K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():615-7. PubMed ID: 15658404
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinopeptide A increases after chorionic villus sampling.
    Al-Gailani F; Elias S; Simpson JL; Green D
    Prenat Diagn; 1987 Oct; 7(8):557-60. PubMed ID: 3684963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.